Clinical Trials in Odesa, Ukraine
12 recruiting
Showing 1–13 of 13 trials
Recruiting
Phase 3
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
Alzheimer DiseaseAgitation
Bristol-Myers Squibb600 enrolled255 locationsNCT06937229
Recruiting
Phase 3
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Solid TumorsHematologic Malignancies
Merck Sharp & Dohme LLC3,500 enrolled782 locationsNCT03486873
Recruiting
Phase 3
MK-3475A±Calderasib (MK-1084) in Completely Resected Stage IIA-IIIB (N2) KRAS G12Cm NSCLC (MK-1084-013)
Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC400 enrolled49 locationsNCT07431827
Recruiting
Phase 3
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-2)
Alzheimer Disease
Bristol-Myers Squibb352 enrolled141 locationsNCT07011745
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
Bipolar DisorderMania
Bristol-Myers Squibb424 enrolled103 locationsNCT07140913
Recruiting
Clinical and Molecular Studies in Families With Inherited Eye Disease
Inherited Eye Disease
National Eye Institute (NEI)5,000 enrolled10 locationsNCT02771236
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)
Bipolar Disorder Type I With Mania or Mania With Mixed Features
Bristol-Myers Squibb274 enrolled78 locationsNCT06951711
Recruiting
Phase 3
A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)
Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC310 enrolled5 locationsNCT07554339
Recruiting
Validation of the Odesa Criteria 2026 for Autoimmune Pancreatitis
Pancreatic CancerChronic PancreatitisIgG4-Related Diseases+1 more
Military Medical Clinical Center of the Southern Region, Ukraine82 enrolled2 locationsNCT07536841
Recruiting
Phase 3
An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With Hyperkalaemia
Hyperkalaemia
AstraZeneca140 enrolled70 locationsNCT03813407
Recruiting
Phase 3
Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia
Schizophrenia
Gedeon Richter Plc.330 enrolled57 locationsNCT03817502
Recruiting
Assessing of Artificial Intelligence-based Software Platform for Diabetic Retinopathy Screening
Diabetic Retinopathy
The Filatov Institute of Eye Diseases and Tissue Therapy200 enrolled1 locationNCT06879834
Recruiting
European Disease Registry on Retinopathy of Prematurity (ROP)
Retinopathy of Prematurity
University Medicine Greifswald3,000 enrolled59 locationsNCT04939571